Sponsors
Gold Sponsors
Novartis
Our vision is to reimagine medicine and discover new ways to improve and extend people’s lives. We utilise science-based innovation to address some of society’s most challenging healthcare issues. Our vision is to be a trusted leader in changing the practice of medicine and we aspire to approach things differently – to make discoveries that take medicine in new directions.
Our strategy is to deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. To support this strategy, we have clear focus areas and priorities to create value for our company, our shareholders and society. We aim to provide a shareholder return that rewards those who invest their money, time, and ideas in our company.
We are Novartis, and we are reimagining medicine.
Gilead
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Based in Melbourne, Gilead Sciences Australia and New Zealand employs over 100 people.
Mallinckrodt
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Therakos® is a specialty brand of Mallinckrodt that focuses on the delivery of Extracorporeal Photopheresis (ECP) Immunomodulation. The THERAKOS® CELLEX® Photopheresis System is the world’s only fully integrated closed ECP system and is used by over 300 treatment centres in over 30 countries worldwide. To learn more about this product, visit our website and refer to the full Product Information before prescribing therakos.com.au.
Silver Sponsors
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a global Biopharmaceutical Company whose purpose is to transform the lives of patients and their families through innovation. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options so they can live their lives more fully.
We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in Neuroscience and Haematology/Oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science.
Jazz Pharmaceuticals has employees around the globe including Australia and New Zealand, serving patients in nearly 75 countries.
Incyte
Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
Since 2002, Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders. The Company is advancing a diversified portfolio of clinical candidates across Oncology and Inflammation & Autoimmunity.
Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia. For more information, visit Incyte.com and follow @Incyte.
Pfizer
Technology is not only changing our lives, but also revolutionizing human health. By uniting transformational technology and cutting-edge science, Pfizer is pioneering biopharmaceutical innovations that not only treat difficult diseases—but can cure or prevent them. Every day, Pfizer is working to discover breakthroughs that change patients’ lives and opening new worlds of medical possibilities. We’re applying equal intelligence and passion to help ensure these treatments and therapies are accessible to all. Pfizer is amplifying the power of science and technology, daring more courageously and inquiring more deeply to make what was once unimaginable a reality.
Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader, committed to bringing Better Health and a Brighter Future to patients, by translating science into highly-innovative medicines. Takeda focuses on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
Other Sponsors
